The U.S. home price reports revealed big June gains that extended the streak of outsized increases to 13 months, as the S&P Case Shiller index rose 2.0%, while the FHFA home price index rose 1.6%, […]
US Home Prices Continue Record Steep Climb Up (S&P Case-Shiller) Read More »
Comrit Investors has extended a tender offer for the sale of 18.3 million shares of CIM Real Estate Finance Trust for $5.01 per share in cash. In fact, the Securities and Exchange Commission (SEC) records show the
Comrit Makes Tender Offer For CIM Real Estate Finance Trust Read More »
Today’s U.S. reports revealed only a tiny Q2 GDP hike to 6.6% from 6.5% that fell short of our assumptions, with a slightly leaner than assumed final sales gain but an even weaker inventory path,
A Tiny U.S. GDP Hike and Fairly Flat Claims Read More »
Housing starts undershot estimates with a -7.0% July drop to a 3-month low of 1.534 mln, though it followed 55k in upward revisions that took the edge off the surprise. Starts remain well below the
US Housing Starts Drop, But Gains Elsewhere Read More »
The U.S. jobs report was stellar on every front with a stronger than expected climb in July nonfarm payrolls, big upward revisions to May and June, a hefty increase in earnings, and solid hours worked.
Weekly Stock Market Report: Moving Toward Normalization… Inflation? Read More »
The factory report beat estimates with a 1.5% June headline orders bounce and a huge 1.4% ex-transportation increase, alongside a 2.0% (was 2.1%) transportation gain. We saw upwardly-revised respective May gains of 2.3% (was 2.1%),
Factory Orders, Shipments and Inventories Beat Estimates Read More »
Key drivers for the week of August 2, 2021 TIP – This is a 1-minute brief bullet-point summary. This tool gives investors and financial professionals a quick and simple list on what to look out
Fed Chair Powell quipped that this was the FOMC’s “first deep dive” into QE tapering discussions. The outcome didn’t make any new waves and in fact, the results of this meeting calmed the seas of
The FOMC’s Deep Dive into QE Tapering – What You Need to Know Read More »
Biopharmaceutical stocks are all the rage these days with investors. Atossa Therapeutics (NASDAQ: ATOS) is a promising stock in the sector that investors shouldn’t ignore. So what is going on with ATOS stock? Over the
Atossa Therapeutics Stock Dips (NASDAQ: ATOS) Read More »
Key Market Trends Tip: Use it as a quick guide for the direction of major markets in the short term. A client of mine used to call me almost daily asking about the direction the
Weekly Stock Market Report: Delta Dents Global Growth Read More »
Get free professional market insights and stock/ETF reports that contain actionable opportunities written by a former financial advisor and Capitalist who has been investing in the markets for 20+ years.
Get Free Stock Picks, Macro Market Events & Options Strategies.
